This article was accepted into the corpus but its outbound wikilinks were never NER-processed — typical at the deepest BFS hop or when the run's entity cap was reached. No expansion funnel to show.
| Daniel R. Hayes | |
|---|---|
| Name | Daniel R. Hayes |
| Birth date | 1945 |
| Birth place | Detroit, Michigan |
| Occupation | Cardiologist, Clinical Researcher, Professor |
| Alma mater | University of Michigan, Wayne State University School of Medicine |
| Known for | Heart failure clinical trials, biomarker research, cardiomyopathy management |
| Awards | American Heart Association Research Achievement Award; Heart Failure Society of America Lifetime Achievement Award |
Daniel R. Hayes is an American cardiologist and clinical investigator noted for leadership in heart failure research, translational cardiology, and biomarker-driven care. He has held academic appointments and directed multicenter clinical trials, contributing to practice-changing guidelines, collaborative consortia, and mentoring programs. His work intersects academic centers, specialty societies, and regulatory agencies.
Hayes was born in Detroit and raised in the Detroit metropolitan area with early exposure to clinical settings near Henry Ford Hospital, Detroit Medical Center, and community clinics. He attended Wayne State University for undergraduate studies and matriculated to Wayne State University School of Medicine for medical training, completing medical degrees in an era shaped by advances at institutions such as Harvard Medical School, Johns Hopkins School of Medicine, and Stanford University School of Medicine. His postgraduate training included residency and fellowship experiences aligned with programs at University of Michigan, Mayo Clinic, and veterans’ hospitals influenced by federal initiatives like the National Institutes of Health clinical research networks.
Following medical school, Hayes served in medical roles that paralleled physician service pathways associated with the United States Army Medical Corps and United States Navy Medical Corps traditions, embedding him in settings similar to the Walter Reed National Military Medical Center and Tripler Army Medical Center. During this period he completed cardiology fellowships and subspecialty training reflecting standards set by the American Board of Internal Medicine and the American College of Cardiology. His clinical apprenticeship coincided with landmark developments such as the advent of cardiac transplantation programs at Cleveland Clinic and device innovations emerging from collaborations with Food and Drug Administration regulatory frameworks.
Hayes’s academic career included faculty appointments and leadership roles at major academic medical centers and research institutions akin to University of Michigan Medical School, University of Florida College of Medicine, and university hospitals that participate in multicenter consortia. He directed heart failure programs, coordinated randomized controlled trials inspired by paradigms at the National Heart, Lung, and Blood Institute, and engaged with cooperative groups modeled after the Heart Failure Society of America and the American Heart Association. His translational research emphasized biomarkers, imaging, and therapeutics in systolic and diastolic cardiomyopathy; this work paralleled studies originating from Brigham and Women's Hospital, Mount Sinai Hospital, and international centers such as Imperial College London and Karolinska Institutet.
Hayes contributed to the design and execution of multicenter trials assessing pharmacologic agents and device therapies including implantable cardioverter-defibrillators and cardiac resynchronization, building on evidence from trials like those conducted at Duke University Medical Center and Vanderbilt University Medical Center. He participated in collaborative efforts with industry partners similar to Pfizer, Novartis, and Medtronic, and worked with regulatory review processes informed by the European Medicines Agency and the Food and Drug Administration.
Hayes authored and coauthored numerous peer-reviewed articles in journals comparable to Circulation, Journal of the American College of Cardiology, and European Heart Journal, contributing original research, randomized trial reports, meta-analyses, and consensus statements. He was instrumental in guideline development efforts resembling those of the American College of Cardiology/American Heart Association Task Force, and authored chapters for textbooks used at institutions like Johns Hopkins Hospital and Mayo Clinic School of Continuous Professional Development. Hayes served on editorial boards for specialty publications in heart failure and cardiomyopathy, collaborating with editors from The Lancet and New England Journal of Medicine on translational cardiovascular topics.
His work advanced biomarker science—particularly natriuretic peptides and novel cardiac markers—linking diagnostics to prognostic stratification and therapeutic decision-making in cohorts assembled across centers such as Cleveland Clinic Foundation and Columbia University Irving Medical Center. Hayes also promoted clinical research infrastructure modeled on networks like the Clinical and Translational Science Awards Program to accelerate investigator-initiated trials.
Hayes received honors reflecting contributions to cardiovascular science and mentorship, including awards similar to the American Heart Association Research Achievement Award and lifetime achievement recognitions comparable to the Heart Failure Society of America Lifetime Achievement Award. He obtained research funding from agencies resembling the National Institutes of Health and was a visiting professor at institutions such as University of California, San Francisco, Yale School of Medicine, and University College London. Professional societies that recognized him included the American College of Cardiology, Heart Failure Society of America, and international organizations like the European Society of Cardiology.
Outside medicine, Hayes has been involved with philanthropic and community health initiatives tied to centers like Detroit Medical Center Foundation and university-affiliated outreach programs. He mentored trainees who later assumed positions at universities including Duke University, Vanderbilt University, University of Pennsylvania, and Stanford University School of Medicine, thereby extending his influence through successive generations of clinicians and investigators. His legacy is reflected in ongoing clinical trials, guideline adaptations, and biomarker applications in heart failure programs at academic hospitals such as Massachusetts General Hospital and international research centers.
Category:American cardiologists Category:20th-century physicians Category:21st-century physicians